WK_Seto Profile Banner
Wai-Kay Seto Profile
Wai-Kay Seto

@WK_Seto

Followers
169
Following
11
Media
9
Statuses
23

Academic Gastroenterologist. Hepatologist. Clinical Professor at @HKUMed

Joined June 2009
Don't wanna be here? Send us removal request.
@WK_Seto
Wai-Kay Seto
1 year
RT @Gut_BMJ: #GUTAbstract by Mao et al on. "Optimal glycaemic control and the reduced risk of colorectal adenoma and cancer in patients wit….
0
4
0
@WK_Seto
Wai-Kay Seto
2 years
RT @MAIDEN_MAFLD: A BIG thanks to this panel of esteemed leaders of our global liver community for drawing attention to the threat of #MAFL….
0
29
0
@WK_Seto
Wai-Kay Seto
2 years
RT @waikleung_hk: Prevalence of H pylori is decreasing but still affect >40% of the world population. Concerted efforts are needed to furth….
0
6
0
@WK_Seto
Wai-Kay Seto
2 years
Can managing hepatitis B be like diabetes? "Shared-care" between primary & specialty care?.It works! Has better coverage! & cost-effective!.Read the article in @LancetRH_WPac .Thanks to @Prof_Lei_Zhang , William Wong, @DrJasonJOng and many others.@hkumed
Tweet media one
0
3
8
@WK_Seto
Wai-Kay Seto
2 years
Old-style academic output! Never thought I would be editing an academic book. well here is the first edition! My sincere thanks to my fantastically efficient co-editor Prof Mohammed Eslam of @Sydney_Uni and to the many many contributors!.#hepatitis #liver @hkumed
Tweet media one
1
0
11
@WK_Seto
Wai-Kay Seto
3 years
RT @loeymak: It is my great honour to present the work of our group in #TLM2022 organized by the #AASLD. Learned so much from this meeting….
0
2
0
@WK_Seto
Wai-Kay Seto
3 years
RT @hkumed: HKUMed has achieved a record ranking of 13th place in the clinical and health subject of the Times Higher Education World Unive….
0
28
0
@WK_Seto
Wai-Kay Seto
3 years
Liver fat and hepatitis B: partners in crime?. Generally speaking? Yes perhaps. Always? Not so. Read the meta-analysis from the link below: @HEP_Journal . @CheungKaShingM2 @loeymak @jamesyyfung . @hkumed @TelAvivUni @CUHKMedicine @dukenus @SNUnow
Tweet media one
0
7
14
@WK_Seto
Wai-Kay Seto
3 years
RT @loeymak: We should aim for better glycemic control among people living with both chronic hepatitis B and type 2 DM. See editorial: http….
Tweet card summary image
journals.lww.com
An abstract is unavailable.
0
2
0
@WK_Seto
Wai-Kay Seto
3 years
If living with hepatitis B, good diabetes control also protects your liver. Read the Hepatology article:. @loeymak @RexWHHui @leechihopaul @DavidLui_HKU @jamesyyfung . @HEP_Journal @hkumed . #diabetes #Liver #hbv
Tweet media one
0
5
10
@WK_Seto
Wai-Kay Seto
3 years
Crowdsourcing - digital innovation to promote viral hepatitis testing via social media. Thanks to @JosephTucker @WeimingTang3 . Read it at @npjDigitalMed #DigitalHealth #HBV #HCV #hepatitis #crowdsourcing. @sesh_global @hkumed @LSHTM @uncglobalhealth
0
4
7
@WK_Seto
Wai-Kay Seto
3 years
If a patient with chronic hepatitis B achieves functional cure, there is a biomarker that predicts the uncommon occurrence of liver cancer. Published in Clinical Infectious Diseases. @CIDJournal .#hbv #fibrosis.@loeymak @RexWHHui @jamesyyfung .@hkumed
Tweet media one
0
2
16
@WK_Seto
Wai-Kay Seto
3 years
The potentials of artificial intelligence in diagnosing liver cancer. A demonstration of interdisciplinary research. #ilc2022 #easl #london #livercancer #ai #DeepLearning .@hkumed
Tweet media one
0
4
26
@WK_Seto
Wai-Kay Seto
3 years
Novel magnetic resonance metrics for newly-diagnosed liver cancer. Collaboration between Medicine, Surgery, Radiology and Pathology; @hkumed & HK Sanatorium. #livercancer #mri #fibrosis #fattyliver #hepatitis. Read the article at
Tweet media one
0
0
10
@WK_Seto
Wai-Kay Seto
3 years
RT @FrontMicrobiol: New Research: Alleviation of Hepatic Steatosis: Dithizone-Related Gut Microbiome Restoration During Paneth Cell Dysfunc….
Tweet card summary image
frontiersin.org
Non-alcoholic fatty liver disease (NAFLD), the world’s most common chronic liver disease, is increasingly linked to gut dysbiosis. Paneth cells secrete antim...
0
3
0
@WK_Seto
Wai-Kay Seto
4 years
Decision-making during HBV therapeutics. @AsanMedicalCtr @hkumed @UofT @q_nationaltaiwa @smu_medical @GileadSciences @KingsCollegeLon @LaStatale . Find the full article here:
Tweet card summary image
onlinelibrary.wiley.com
These data, together with recommendations from various CHB treatment guidelines, support the concept of switching to TAF in individual patients with CHB, including those at risk of bone or renal...
@APandT
roypounder.apt
4 years
'Review: switching patients with chronic hepatitis B to tenofovir alafenamide—a review of current data'.#HBV #tenofovir_alafenamide #hepatology.READ FREE OPEN ACCESS at
Tweet media one
0
0
1
@WK_Seto
Wai-Kay Seto
4 years
Eliminate viral hepatitis!. @MonashUni @xjtuofficial @hkumed @LancetGH.
@Prof_Lei_Zhang
Lei Zhang (Monash University)
4 years
Central Clinical School News Blog: Universal HBV screening in China is cost-effective.
0
0
3
@WK_Seto
Wai-Kay Seto
4 years
RT @JHepatology: 🆕Article in press❕. Probability of HBsAg loss after nucleo(s)tide analogue withdrawal depends on #HBV genotype and viral a….
0
18
0
@WK_Seto
Wai-Kay Seto
4 years
Always excited with the work of my very good friend👏👏 @Kelvinkwto @hkumed.
@Kelvinkwto
Kelvin To
4 years
We are excited to share our new findings on the neutralization of omicron variant by pediatric vaccine recipient and convalescent sera. @tandfonline @hkumed
Tweet media one
0
1
0